Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-06T12:46:35.275Z Has data issue: false hasContentIssue false
  • English
  • Français

Creutzfeldt-Jakob Disease: Procedures for Handling Diagnostic and Research Materials

Published online by Cambridge University Press:  02 January 2015

Frank O. Bastian  and
Roger A. Jennings
Frank O. Bastian
Affiliation:
Department of Pathology, University of South Alabama, College of Medicine, Mobile, Alabama
Roger A. Jennings
Affiliation:
Department of Pathology, University of South Alabama, College of Medicine, Mobile, Alabama
Get access Rights & Permissions [Opens in a new window]

Extract

There is increasing concern in the medical community regarding the safe handling and storage of biological materials procured from patients with Creutzfeldt-Jakob disease (CJD). Neurosurgeons have refused to operate on CJD patients, pathologists have refused to do autopsies on CJD patients, and hospitals have discharged CJD patients without confirmation of their diagnoses. This attitude was exemplified in the case of a director of a pathology laboratory who was so concerned about the safety of his laboratory personnel that he proposed to incinerate his entire collection of CJD slides. This extreme example is typical of the hysteria common among medical colleagues regarding the safe handling of CJD biological materials.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 5 , Issue 1 , January 1984 , pp. 48 - 51
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gajdusek, DC: Unconventional viruses and the origin and disappearance of Kuru. Science 1977;197:943–960.Google Scholar
2. Duffy, P, Wolf, J, Collins, G, et al: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692.Google ScholarPubMed
3. Bastian, FO: Spiroplasma-like inclusions in Creutzfeldt-Jakob disease. Arch Pathol Lab Med 1979;103:665–669.Google ScholarPubMed
4. Bastian, FO, Hart, MN, Cancilla, PA: Additional evidence of Spiroplasma in Creutzfeldt-Jakob disease. Lancet 1981 ;21:1(8221):660.CrossRefGoogle Scholar
5. Reyes, JM, Hoenig, EM: Intracellular spiral inclusions in cerebral cell processes in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1981;40:1–8.Google Scholar
6. Gray, A, Francis, RJ, Schdtz, CL: Spiroplasma and Creutzfeldt-Jakob disease. Lancet 1980;2:152.Google Scholar
7. Merz, PA, Sumerville, RA, Wisniewski, HM, et al: Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 1981;54:63–74.CrossRefGoogle ScholarPubMed
8. Merz, PA, Rowher, R, Somerville, RA, et al: Scrapie associated fibrils in human Creutzfeldt-Jakob disease. Abstract of American Association of Neuropathologist Fifty-Ninth Annual Meeting, St Louis, June 10, 1983.Google Scholar
9. Bastian, FO, Jennings, RA: Spiroplasma-associated fibrils. Lancet, in press.Google Scholar
10. Bastian, FO, Purnell, DM, Tully, JG: Neuropathology of spiroplasma infection in the rat brain. Am J Pathol, in press.Google Scholar
11. Stanek, G, Hirschl, A, Laber, G: Sensitivity of various spiroplasma strains against ethanol, formalin, glutaraldehyde and phenol. Zbl Boht Hygl Abt OrigBV 1981;174:348–354.Google ScholarPubMed